Palvella Therapeutics, Inc. Increase (Decrease) in Prepaid Rent
Palvella Therapeutics, Inc. (PVLA) reported Increase (Decrease) in Prepaid Rent of $0 for the 9-month period ending 2019-09-30, per its 10-Q filed 2020-11-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidRent · last filed 2020-11-04
- Palvella Therapeutics, Inc. increase (decrease) in prepaid rent for the quarter ending 2019-09-30 was $0.00.
- Palvella Therapeutics, Inc. increase (decrease) in prepaid rent for the quarter ending 2018-09-30 was $0.00.
| Period end | Increase (Decrease) in Prepaid Rent 3 month | Increase (Decrease) in Prepaid Rent 6 month | Increase (Decrease) in Prepaid Rent 6 month as first filed | Increase (Decrease) in Prepaid Rent 9 month | Increase (Decrease) in Prepaid Rent 9 month as first filed |
|---|---|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $0.00 10-Q · filed 2020-11-04 | -$853.00K 10-Q · filed 2019-11-12 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-10 | -$588.00K 10-Q · filed 2019-08-09 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |